About Flamingo Pharmaceuticals Limited
Data last updated:
Flamingo Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 June 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51900MH1985PLC036572. Its GSTIN is 27AAACF4211B1ZE (Maharashtra). The company holds 9 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹6.8 Cr. It was formerly known as Flamingo Impex Limited and Flamingo Impex P Limited. It is led by directors including Parth Ashwin Thacker and Chhotulal Rawa Bhagwat.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 Corporate Park, Mumbai, Maharashtra.
As per the financials filed for FY 2026, the company reported a revenue of ₹636.88 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹96.92 Cr (net margin 15.2%) and EBITDA of ₹160.57 Cr (EBITDA margin 25.2%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 21% over five years.
The company has about 552 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Flamingo Pharmaceuticals. As per MCA filings, the company has open charges of ₹121.37 Cr and satisfied charges of ₹452.45 Cr on record. Court records list 43 cases involving the company, including 7 filed by the company and 36 filed against it; 11 cases are pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹4.54 Cr; the latest was in December 2024. Its 8 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Kusum Healthcare Private Limited with revenue of ₹537.89 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website flamingopharma.com.
Company details
Name history
Flamingo Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Flamingo Impex Limited, and Flamingo Impex P Limited. The current legal name is Flamingo Pharmaceuticals Limited.
| Company Name | Status |
|---|---|
| Flamingo Pharmaceuticals Limited | Current |
| Flamingo Impex Limited | Previous |
| Flamingo Impex P Limited | Previous |
Contact details
Flamingo Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is flamingopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address7/1 Corporate Park Sion – Trombay Road P.O.Box No. : 27257, Chembur, Mumbai, Maharashtra, India – 400071
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Flamingo Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Flamingo Pharmaceuticals operates one associated brand: Flamingo Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and distributes pharmaceutical products to over 50 countries worldwide. | flamingopharma.com |
Business activity
The main business activity of Flamingo Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Flamingo Pharmaceuticals Limited, buy the company report.
Financials of Flamingo Pharmaceuticals Limited
FY 2025 filings availableFlamingo Pharmaceuticals Limited reported revenue of ₹636.88 Cr (up 25% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 25% growth in the latest year. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹160.57 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹96.92 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.2% | ||||
| Net Profit Margin | 15.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Flamingo Pharmaceuticals Limited, buy the company report.
Board of directors and KMP of Flamingo Pharmaceuticals Limited
Flamingo Pharmaceuticals Limited currently reports 5 directors and 1 key managerial person. 23 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kumar | Ceo | 02 Aug 2023 | 3 Years 2 Months | Current |
| Parth Ashwin Thacker Also directs: Rotaline Molekule LLP, Flamingo Infra Developers LLP, Mini Med Laboratories LLP and 1 more | Director | 10 Nov 2023 | 2 Years 11 Months | Current |
| Chhotulal Rawa Bhagwat | Director | 25 Oct 2022 | 4 Years 0 Months | Current |
| Pranay Ashwin Thacker | Director | 08 Jun 2021 | 5 Years 4 Months | Current |
| Ashwin Jethalal Thacker Also directs: Rotaline Molekule LLP, Flamingo Infra Developers LLP, Mini Med Laboratories LLP and 1 more | Director | 23 Jun 1986 | 40 Years 4 Months | Current |
| Meena Sanjiv Kapadi | Director | 28 Sep 2022 | 4 Years 0 Months | Current |
Peer comparison
Flamingo Pharmaceuticals Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Flamingo Pharmaceuticals Limitedthis company | ₹636.88 Cr (FY 2026) | ₹96.92 Cr | 15.2% | 25.0% | 552 | Mumbai, Maharashtra, India |
| Kusum Healthcare Private Limited | ₹537.89 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India | |||
| Unison Pharmaceuticals Private Limited | ₹537.1 Cr (FY 2025) | 23.0% | Ahmedabad, Gujarat, India | |||
| Maneesh Pharmaceuticals Limited | ₹534.48 Cr (FY 2022) | 28.0% | Mumbai, Maharashtra, India | |||
| Mapaex Health and Personalcare Private Limited | ₹514.15 Cr (FY 2024) | 23.0% | Bhopal, Madhya Pradesh, India | |||
| Cronus Pharma Specialities India Private Limited | ₹484.74 Cr (FY 2025) | 64.0% | Hyderabad, Telangana, India | |||
| Aarey Drugs and Pharmaceuticals Limited | ₹483.76 Cr (FY 2025) | 20.0% | Thane, Maharashtra, India | |||
| Syncom Formulations (India) Limited | ₹482.45 Cr (FY 2025) | 74.0% | Mumbai, Maharashtra, India | |||
| Karnataka Antibiotics and Pharmaceuticals Limited | ₹479.24 Cr (FY 2022) | 11.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Flamingo Pharmaceuticals Limited, buy the company report.
Auditor
Flamingo Pharmaceuticals Limited is audited by Pravin Sarvaiya & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Pravin Sarvaiya & Co. | FY 2023 | 114753W |
Shareholding
The shareholding of Flamingo Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Flamingo Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Feb 2023 | 100691074 | Others | ₹22 Lakh | Open | |
| 18 Nov 2022 | 100651360 | Others | ₹18.15 Cr | Open | |
| 22 Feb 2022 | 100546326 | Others | ₹20 Cr | Open | |
| 09 Oct 2015 | 10600162 | Others | ₹13 Cr | Open | |
| 29 Sep 2015 | 10600160 | Others | ₹5 Cr | Open |
To see the full charge records of Flamingo Pharmaceuticals Limited, buy the company report.
Total charge records: 39 View all charges
Deals & funding
Flamingo Pharmaceuticals Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹4.54 Cr; the latest was in December 2024.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2008 | Funding round | ₹4.54 Cr | Investors: Mini Med Laboratories Pvt Ltd , 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Flamingo Pharmaceuticals Limited has 43 court cases on record: 7 filed by Flamingo Pharmaceuticals, 36 filed against it. 11 cases are pending and 32 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 38 | 33 | 11 |
| High courts | 4 | 2 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 43)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, RAJKOT, Gujarat | Criminal complaint | Filed against the company by Orchev Pharma Pvt. Ltd. Viren Vasant Patel | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed against the company by Lincoln Pharmaceuticals Ltd. | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Complaint ULP) | Filed against the company by an individual | Pending |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Complaint ULP) | Filed against the company by an individual | Pending |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Complaint ULP) | Filed against the company by an individual | Pending |
To see the full case history of Flamingo Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Flamingo Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Flamingo Pharmaceuticals Limited has a workforce of 552 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Flamingo Pharmaceuticals has 9 GST registrations: 1 active and 8 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACF4211B1ZE | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Flamingo Pharmaceuticals Limited, buy the company report.
Recent activity
Flamingo Pharmaceuticals Limited has 26 board changes on record since 1986: 6 appointments and 20 cessations. The latest: Parth Ashwin Thacker ceased to be Additional Director on 25 Sep 2024.
102 earlier events are in the company report.
Frequently asked questions
Flamingo Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 June 1985 (41+ years old) and is registered under CIN U51900MH1985PLC036572.
Flamingo Pharmaceuticals has 6 current directors and KMP:
- Parth Ashwin Thacker - Director
- Chhotulal Rawa Bhagwat - Director
- Pranay Ashwin Thacker - Director
- Ashwin Jethalal Thacker - Director
- Meena Sanjiv Kapadi - Director
- Sunil Kumar - Ceo
The latest financial statements of Flamingo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Flamingo Pharmaceuticals is 27AAACF4211B1ZE, registered in Maharashtra. The company has 9 GST registrations in all, of which 1 is active and 8 are cancelled or inactive.
The CIN (Corporate Identification Number) of Flamingo Pharmaceuticals is U51900MH1985PLC036572. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Flamingo Pharmaceuticals has 43 court cases on record: 7 filed by the company and 36 filed against it. 11 are pending. Most are in the district courts.
Flamingo Pharmaceuticals was incorporated on 12 June 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.
Flamingo Pharmaceuticals has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹4.54 Cr; the latest was in December 2024.
The peers of Flamingo Pharmaceuticals by revenue are Kusum Healthcare Private Limited, Unison Pharmaceuticals Private Limited, Maneesh Pharmaceuticals Limited, Mapaex Health and Personalcare Private Limited, Cronus Pharma Specialities India Private Limited and 3 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Parth Ashwin Thacker ceased to be Additional Director on 25 Sep 2024. Parth Ashwin Thacker was appointed as Director on 10 Nov 2023. Sunil Kumar was appointed as CEO on 02 Aug 2023. Flamingo Pharmaceuticals has 26 board changes on record in total.
Flamingo Pharmaceuticals can be reached through the website flamingopharma.com. Its registered office is in Mumbai, Maharashtra, India.